CPT® Code 84081

The CPT® Code 84081 refers to the assessment of fetal lung maturity through the testing of phosphatidylglycerol (PG). Phosphatidylglycerol is a specific type of lipid that becomes detectable in the amniotic fluid only when the fetal lungs have reached maturity. This testing is crucial as it helps healthcare providers evaluate the likelihood of neonatal respiratory distress syndrome (RDS), which is also known as hyaline membrane disease, occurring after the baby is born. The presence of PG in the amniotic fluid indicates that the lungs are sufficiently developed, thereby reducing the risk of RDS. The test is typically conducted on amniotic fluid collected prior to delivery, and its results can influence clinical decisions regarding the management of premature labor. Specifically, the test helps determine whether to suppress premature labor or to allow the delivery to proceed based on the maturity of the fetal lungs. Additionally, this test may be indicated in situations where there are complications affecting the health of the mother and/or fetus, guiding the decision on whether it is safe to induce labor. The assay for PG is performed using a method known as latex agglutination, which is a reliable technique for detecting the presence of this lipid in the amniotic fluid. If phosphatidylglycerol is found, it suggests a low risk of neonatal respiratory distress syndrome, providing reassurance to both the healthcare team and the family.